Disparate Intent-to-Treat Outcomes for Pediatric Liver Transplantation Based on Indication

Table 3

Multivariable analysis: intent-to-treat mortality.

Variable	Intent-to-treat mortality
	value	95% CI	Hazard ratio
Age	0	1.01–1.04	1.02
Indication
Hepatoblastoma	0	2.61–5.26	3.71
Autoimmune cirrhosis	0.02	1.09–3.23	1.87
AHN	0	1.27–2.49	1.78
Metabolic disorders	0.51	0.78–1.63	1.13
Other	0	1.68–2.74	2.15
Race and ethnicity
White	0.15	0.71–1.05	0.86
Black	0.97	0.78–1.25	0.99
Height (cm)
Donor-recipient height difference over 60 cm	0.99	0.80–1.23	0.99
Life support	0	1.84–3.08	2.38
Dialysis	0	1.40–3.30	2.15
Insurance
Private	0.92	0.72–1.32	0.98
Public	0.02	1.06–1.90	1.42
Status 1	0.67	0.74–1.21	0.94
Region
AK, HI, ID, MT, OR, WA	0.05	0.26–1.00	0.51
Initial laboratory values
Bilirubin	0.14	0.99–1.01	1.00
INR	0.50	0.96–1.07	1.01
Creatinine	0.12	0.93–1.77	1.28
Albumin	0	0.68–0.86	0.76